Unraveling Resistance in Lung Cancer Immunotherapy: Clinical Milestones, Mechanistic Insights, and Future Strategies
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26189244 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Maria Vitale und 8 weiteren Autor:innen. Beteiligte Einrichtung: CEINGE-Biotecnologie Avanzate Franco Salvatore, 80145 Naples, Italy. Hauptthemen laut MEDLINE: Lung Neoplasms, Immunotherapy, Drug Resistance, Neoplasm, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Over the last decade, immunotherapy has revolutionized lung cancer treatments, particularly in non-small cell lung cancer, where immune checkpoint inhibitors have achieved significant clinical success. However, high percentages of patients do not respond initially or eventually develop a resistance to these therapies. This review explores the evolution and challenges of immunotherapy in lung cancer, highlighting its clinical milestones and intrinsic and extrinsic resistance mechanisms. We investigate tumor-intrinsic resistance factors, including alterations in antigen presentation, the loss of Beta-2 microglobulin function, impaired interferon signaling, immune editing, epigenetic modifications, and tumor-extrinsic resistance, such as an immunosuppressive lung tumor microenvironment, dysregulated cytokine profiles, and the upregulation of immune checkpoints. Then, we focus on the emerging role of resistance biomarkers and the development of personalized treatment strategies to overcome these challenges. The complex interplay between tumor biology and immune modulation in lung cancer paves the way for novel approaches for improving the effectiveness of immunotherapeutic treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CEINGE-Biotecnologie Avanzate Franco Salvatore, 80145 Naples, Italy.
- Department of Translational Medical Sciences, University of Campania L. Vanvitelli, 80131 Naples, Italy.
- Department of Pneumology and Oncology, Monaldi Hospital, AORN dei Colli, 80131 Naples, Italy.
- Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, 80131 Naples, Italy.
- U.O.C. Clinica Pneumologica L. Vanvitelli, Monaldi Hospital, AORN dei Colli, 80131 Naples, Italy.
ORCID-Profile: Maria Vitale, Raffaella Pagliaro, Giuseppe Viscardi, Lucio Pastore, Susan F Campbell, Andrea Bianco, Filippo Scialò
Zitieren
APA
Vitale, M., Pagliaro, R., Viscardi, G., Pastore, L., Castaldo, G., Perrotta, F., Campbell, S. F., Bianco, A., & Scialò, F. (2025). Unraveling Resistance in Lung Cancer Immunotherapy: Clinical Milestones, Mechanistic Insights, and Future Strategies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26189244
Vancouver
Vitale M, Pagliaro R, Viscardi G, Pastore L, Castaldo G, Perrotta F, et al. Unraveling Resistance in Lung Cancer Immunotherapy: Clinical Milestones, Mechanistic Insights, and Future Strategies. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26189244
BibTeX
@article{Vitale2025,
author = {Vitale, Maria and Pagliaro, Raffaella and Viscardi, Giuseppe and Pastore, Lucio and Castaldo, Giuseppe and Perrotta, Fabio and Campbell, Susan F and Bianco, Andrea and Scialò, Filippo},
title = {Unraveling Resistance in Lung Cancer Immunotherapy: Clinical Milestones, Mechanistic Insights, and Future Strategies},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26189244}
}
EUVIMED